Full Press Release Details
BridgeBio Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4).
BBIO
BridgeBio Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Key Takeaway: BridgeBio Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)